Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesProtective actions of sex steroid hormones in Alzheimer's disease
Frontiers in Neuroendocrinology, 06/24/09
Pike CJ et al. – A review of the protective actions of sex steroid hormones in Alzheimer’s disease (AD) reports that the successful use of hormone therapies in aging men and women to delay, prevent, and or treat AD is pending research to optimize key parameters of hormone therapy and development of selective estrogen- and androgen-receptor modulators.
Methods- Review of the protective actions of sex steroid hormones in AD
- Etrogens and progestogens depletion hypothesized to increase susceptibility to AD pathogenesis -- supported by epidemiologic evidence but refuted by some clinical findings
- Experimental evidence for neuroprotective actions of estrogen for AD prevention: promotion of neuron viability and reduction of beta-amyloid accumulation
- Diminished neural responsiveness to estrogen with age and reduced neuroprotective actions of estrogen limit use of hormone therapies in aged women
- Modulation of estrogen neuroprotective actions by progestogens
- Continuous progestogen exposure associated with inhibition of estrogen actions vs cyclic delivery of progestogens that enhances estrogen neural benefits
- Normal age-related testosterone loss in men associated with increased risk for AD
- Testosterone as an endogenous neuroprotective factor increases neuronal resilience and reduces beta-amyloid accumulation
- Androgen neuroprotective effects mediated both directly by androgen pathway activation and indirectly by aromatization to estradiol and initiation of protective estrogen signaling mechanisms
Related Articles
Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09
Relevance Score: 71%%
High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09
Relevance Score: 70%%
Activated astrocytes: a therapeutic target in Alzheimer's disease?
Expert Review of Neurotherapeutics, 11/19/09
Relevance Score: 69%%
Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09
Relevance Score: 69%%
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease
Expert Review of Neurotherapeutics, 11/19/09
Relevance Score: 68%%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Familial Cervical Paragangliomas with Lymph Node Metastasis Expressing Somatostatin Receptor Type 2A
Endocrine Pathology, 11/25/09
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
Sponsor
Article Search
Sponsor